Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P129907-50mg | 50mg | In stock | $129.90 | |
P129907-250mg | 250mg | In stock | $585.90 | |
P129907-1g | 1g | In stock | $2,106.90 | |
P129907-5g | 5g | In stock | $9,477.90 | |
P129907-25g | 25g | In stock | $42,646.90 |
Selective PPARγ agonist
Synonyms | Pioglitazone|111025-46-8|Actos|Glustin|Zactos|105355-27-9|Pioglitazona|Pioglitazonum|5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione|Pioglitazonum [INN-Latin]|Pioglitazona [INN-Spanish]|Piozone|Pioglu|U 72107|AD-4833|Pioglitazone (Actos) |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST, CHANNEL BLOCKER |
Mechanism of action | Agonist of Peroxisome proliferator-activated receptor-γ;Channel blocker of TRPM3 |
Product Description | Pioglitazone (Actos) is a selective peroxisome proliferator-activated receptor gamma stimulator. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488179857 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179857 |
IUPAC Name | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
INCHI | InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) |
InChi Key | HYAFETHFCAUJAY-UHFFFAOYSA-N |
Canonical SMILES | CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 |
Isomeric SMILES | CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 |
Alternate CAS | 112529-15-4 |
PubChem CID | 4829 |
Molecular Weight | 356.44 |
PubChem CID | 4829 |
---|---|
ChEBI | CHEBI:8228 |
CAS Registry No. | 111025-46-8 |
ChEMBL Ligand | CHEMBL595 |
DrugBank Ligand | DB01132 |
BindingDB Ligand | 50049240 |
Wikipedia | Pioglitazone |
NURSA Ligand | 10.1621/KQK3B7FMLX |
PEP | pioglitazone |
DrugCentral Ligand | 2179 |
PubChem SID | 488179857 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2401029 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F23271048 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327706 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327707 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327710 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327801 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327808 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327817 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327819 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327820 | Certificate of Analysis | Jun 03, 2023 | P129907 |
F2327852 | Certificate of Analysis | Jun 03, 2023 | P129907 |
D1513136 | Certificate of Analysis | Nov 16, 2022 | P129907 |
Solubility | Soluble in water (<1 mg/ml at 25 °C), DMSO (15 mg/ml at 25 °C), DMF (2.5 mg/ml), ethanol (<1 mg/ml at 25 °C), and 1:1 solution of DMSO:PBS (pH 7.2) (~ 0.1 mg/ml). |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed H312:Harmful in contact with skin H332:Harmful if inhaled H302+H312+H332:Harmful if swallowed, in contact with skin or if inhaled |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P317:Get emergency medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
1. Morató L, Galino J, Ruiz M, Calingasan NY, Starkov AA, Dumont M, Naudí A, Martínez JJ, Aubourg P, Portero-Otín M et al.. (2013) Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.. Brain, 136 (Pt 8): (2432-43). [PMID:23794606] |